• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Background Patients with congenital heart disease (CHD) are at lifelong high risk of infective
endocarditis (IE). The risk of IE presumably differs among different CHD, but little knowledge …

Abstract Background and Aims Patients with congenital heart disease (CHD) form a high-
risk subgroup for infective endocarditis (IE), necessitating tailored prevention and treatment …

Background The incidence of infective endocarditis (IE) has increased in recent decades.
Societal lockdown including reorganization of the healthcare system during the COVID-19 …

Background Patients with tetralogy of Fallot (ToF) are considered at high risk of infective
endocarditis (IE) as a result of altered hemodynamics and multiple invasive procedures …

Background Loss of autonomy associated with nursing home admission (NHA) is a concern
for patients. Yet the incidence of NHA after transcatheter aortic valve replacement (TAVR) is …

Aims Infective endocarditis is a complex and highly mortal disease requiring lengthy
treatment. Physical and mental deconditioning is common. Nonetheless, rehabilitation is …

Aims Myocardial infarction (MI) with cardiogenic shock (CS) and/or out-of-hospital cardiac
arrest (OHCA) are conditions with potential loss of autonomy. In patients with MI, the …

Introduction Antibiotic prophylaxis is recommended for patients considered in high risk of
infective endocarditis (ie, patients with prior infective endocarditis, heart valve prosthesis …